Testing the Combination of Anti-cancer Drugs Actimab-A and Cemiplimab (REGN2810) to Improve Outcomes for Patients With Recurrent Glioblastoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
Ankyra Therapeutics, Inc
Regeneron Pharmaceuticals
University of Iowa
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Inimmune Corporation
OncoNano Medicine, Inc.